Oxalo Therapeutics

Manufacturing · Illinois, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

1452 E 53rd St Fl 2, Chicago, Illinois, ...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Oxalo Therapeutics

Oxalo Therapeutics is focused on developing first-in-class therapeutics aimed at treating rare renal diseases, particularly primary hyperoxaluria, which leads to severe kidney complications. The company is addressing the lack of effective therapies for this ultra-rare disease that affects approximately 5,000 patients in the U.S. and E.U. Additionally, Oxalo is leveraging microbiome-inspired therapy to maintain oxalate homeostasis through innovative peptide therapeutics. Their commitment lies in preserving long-term kidney health for patients suffering from severe and rare kidney diseases caused by oxalate.Explore more
Oxalo Therapeutics's Social MediaPopular SearchesOxalo TherapeuticsOxalo Therapeutics IncOxalo Therapeutics - IncOxalotherapeuticsSIC Code 28,283NAICS Code 32,325Show more

Oxalo Therapeutics Org Chart

PhoneEmail
DA
United States flag for contact location.

Manager, Research Laboratory

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
HH
United States flag for contact location.

Co-Founder, Lead of Research & Development

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Oxalo Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Oxalo Therapeutics

Compare insights from companies similar to Oxalo Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Oxalo Therapeutics

<$5M
1-10
Private
-
2017
DA
Donna ArvansManager, Research Laboratory
<$5M
11-50
Private
$7.5M
2009
<$5M
11-50
Private
-
2018
N/A
<$5M
11-50
Private
-
1995
AF
Andrew FosterExecutive Vice President
<$5M
1-10
Private
-
1999
SR
Stuart RingoldDirector, Operations (North America)
<$5M
11-50
Public
<$5M
1987
HK
Hyun KimVice President, Clinical Development
11-50
Public
$146.3M
2016
DJ
Douglas JermasekExecutive VP, Corporate Strategy
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Oxalo Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Oxalo Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Oxalo Therapeutics.

Oxalo Therapeutics Tech Stack

A closer look at the technologies used by Oxalo Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Oxalo Therapeutics

What is Oxalo Therapeutics's official website?
Oxalo Therapeutics's official website is www.oxalotherapeutics.com
What is Oxalo Therapeutics's Revenue?
Oxalo Therapeutics's revenue is <$5 Million
What is Oxalo Therapeutics's SIC code?
Oxalo Therapeutics's SIC: 28,283
What is Oxalo Therapeutics's NAICS code?
Oxalo Therapeutics's NAICS: 32,325
How many employees does Oxalo Therapeutics have?
Oxalo Therapeutics has 1-10 employees
What industry does Oxalo Therapeutics belong to?
Oxalo Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Oxalo Therapeutics competition?
Oxalo Therapeutics top competitors include: Unicycive Therapeutics, Ember Therapeutics, Glycominds, Genome It All
What technology does Oxalo Therapeutics use?
Some of the popular technologies that Oxalo Therapeutics uses are: Sentry, F5 BIG-IP Platform, F5 BIG-IP Application Security Manager, Google Workspace
What does Oxalo Therapeutics do?

Oxalo Therapeutics is focused on developing first-in-class therapeutics aimed at treating rare renal diseases, particularly primary hyperoxaluria, which leads to severe kidney complications. The company is addressing the lack of effective therapies for this ultra-rare disease that affects approximately 5,000 patients in the U.S. and E.U. Additional... ly, Oxalo is leveraging microbiome-inspired therapy to maintain oxalate homeostasis through innovative peptide therapeutics. Their commitment lies in preserving long-term kidney health for patients suffering from severe and rare kidney diseases caused by oxalate.Read More

What are Oxalo Therapeutics social media links?
Oxalo Therapeutics Linkedin page
Is Oxalo Therapeutics a public company?
Oxalo Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Oxalo Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.